| Market Cap | 5.8B |
| Market Cap (USD) | $796.6M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -1.30 |
| Dividend Yield | - |
| D/E Ratio | 0.36 |
| Current Ratio | 2.56 |
| Market Segment | ChiNext |
| Currency | CNY |
Business Overview
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | C27医药制造业 |
| Market Segment | ChiNext |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 振东制药 |
| Ticker | 300158 |
| Exchange | SZSE |
| Sector | 证监会行业分类 |
| Industry | C27医药制造业 |
| Market Segment | ChiNext |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 5.8B |
| Market Cap (USD) | $796.6M |
| Revenue | 3.0B |
| Net Income | -1.3B |
| P/E Ratio | - |
| EPS | -1.30 |
| Net Margin | -44.9% |
| ROE | -36.4% |
| Dividend Yield | - |
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi, China.